IRS-2 deficiency impairs NMDA receptor-dependent long-term potentiation

Cerebral Cortex

Volumn 22, Issue 8, 2012, Pages 1717-1727

  Martín, Eduardo D ^a   Sánchez Perez, Ana ^b,f   Trejo, José Luis ^c   Martin Aldana, Juan Antonio ^b   Cano Jaimez, Marife ^b   Pons, Sebastián ^d   Acosta Umanzor, Carlos ^b   Menes, Lorena ^b   White, Morris F ^e   Burks, Deborah J ^b  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO CAJAL   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f UNIVERSITY OF VALENCIA   (Spain)

Author keywords

diabetes; insulin receptor signaling; long term potentiation; NMDA receptor; synaptic plasticity

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 2; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; POSTSYNAPTIC DENSITY PROTEIN 95; POSTSYNAPTIC RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE FYN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; INSULIN RESISTANCE; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TETANUS; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; FEMALE; HIPPOCAMPUS; IMMUNOPRECIPITATION; INSULIN RECEPTOR SUBSTRATE PROTEINS; LONG-TERM POTENTIATION; MICE; MICE, KNOCKOUT; PATCH-CLAMP TECHNIQUES; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 84863700380     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhr216     Document Type: Article

References (83)

1. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B, Johnson RS, Kahn CR. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 372:186-190. (Pubitemid 24347839)
2. Artola A, Kamal A, Ramakers GM, Biessels GJ, Gispen WH. 2005. Diabetes mellitus concomitantly facilitates the induction of longterm depression and inhibits that of long-term potentiation in hippocampus. Eur J Neurosci. 22:169-178. (Pubitemid 41059982)
3. Avruch J. 1998. Insulin signal transduction through protein kinase cascades. Mol Cell Biochem. 182:31-48. (Pubitemid 28181646)
4. Baura GD, Foster DM, Porte D, Jr., Kahn SE, Bergman RN, Cobelli C, Schwartz MW. 1993. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest. 92:1824-1830. (Pubitemid 23304549)
5. Beattie EC, Carroll RC, Yu X, Morishita W, Yasuda H, von Zastrow M, Malenka RC. 2000. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat Neurosci. 3:1291-1300.
6. Biessels GJ, Kamal A, Ramakers GM, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. 1996. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes. 45: 1259-1266. (Pubitemid 26296329)
7. Bliss TV, Collingridge GL. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:31-39. (Pubitemid 23020772)
8. Burks DJ, Font de Mora J, Schubert M, Withers DJ, Myers MG, Towery HH, Altamuro SL, Flint CL, White MF. 2000. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature. 407:377-382.
9. Chiu SL, Chen CM, Cline HT. 2008. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron. 58:708-719. (Pubitemid 351778469)
10. Choudhury AI, Heffron H, Smith MA, Al-Qassab H, Xu AW, Selman C, Simmgen M, Clements M, Claret M, Maccoll G, et al. 2005. The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest. 115:940-950. (Pubitemid 40489398)
11. Clarke DW, Mudd L, Boyd FT, Jr., Fields M, Raizada MK. 1986. Insulin is released from rat brain neuronal cells in culture. J Neurochem. 47:831-836. (Pubitemid 16029565)
12. Collingridge GL, Kehl SJ, McLennan H. 1983. Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J Physiol. 334:33-46. (Pubitemid 13176081)
13. Craft S. 2007. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res. 4:147-152. (Pubitemid 46557503)
14. Davidson D, Viallet J, Veillette A. 1994. Unique catalytic properties dictate the enhanced function of p59fynT, the hemopoietic cellspecific isoform of the Fyn tyrosine protein kinase, in T cells. Mol Cell Biol. 14:4554-4564.
15. Desrocher M, Rovet J. 2004. Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychol. 10:36-52. (Pubitemid 38418932)
16. Dou JT, Chen M, Dufour F, Alkon DL, Zhao WQ. 2005. Insulin receptor signaling in long-term memory consolidation following spatial learning. Learn Mem. 12:646-655. (Pubitemid 41770090)
17. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB. 2003. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 27: 260-268. (Pubitemid 36255810)
18. English JD, Sweatt JD. 1996. Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation. J Biol Chem. 271:24329-24332. (Pubitemid 26333160)
19. Feng W, Zhang M. 2009. Organization and dynamics of PDZ-domainrelated supramodules in the postsynaptic density. Nat Rev Neurosci. 10:87-99.
20. Folli F, Bonfanti L, Renard E, Kahn CR, Merighi A. 1994. Insulin receptor substrate-1 (IRS-1) distribution in the rat central nervous system. J Neurosci. 14:6412-6422. (Pubitemid 24333063)
21. Garcia-Estrada J, Garcia-Segura LM, Torres-Aleman I. 1992. Expression of insulin-like growth factor I by astrocytes in response to injury. Brain Res. 592:343-347.
22. Garcia-Segura LM, Perez J, Pons S, Rejas MT, Torres-Aleman I. 1991. Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain. Brain Res. 560:167-174.
23. Grant SG, O'Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER. 1992. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science. 258:1903-1910. (Pubitemid 23026728)
24. Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ, et al. 2005. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell. 122:337-349. (Pubitemid 41127137)
25. Hestrin S, Nicoll RA, Perkel DJ, Sah P. 1990. Analysis of excitatory synaptic action in pyramidal cells using whole-cell recording from rat hippocampal slices. J Physiol. 422:203-225. (Pubitemid 20109856)
26. Imaeda A, Kaneko T, Aoki T, Kondo Y, Nagase H. 2002. DNA damage and the effect of antioxidants in streptozotocin-treated mice. Food Chem Toxicol. 40:979-987. (Pubitemid 34626706)
27. Kamal A, Biessels GJ, Gispen WH, Ramakers GM. 2006. Synaptic transmission changes in the pyramidal cells of the hippocampus in streptozotocin-induced diabetes mellitus in rats. Brain Res. 1073-1074:276-280.
28. Kanterewicz BI, Urban NN, McMahon DB, Norman ED, Giffen LJ, Favata MF, Scherle PA, Trzskos JM, Barrionuevo G, Klann E. 2000. The extracellular signal-regulated kinase cascade is required for NMDA receptor-independent LTP in area CA1 but not area CA3 of the hippocampus. J Neurosci. 20:3057-3066. (Pubitemid 30263122)
29. Kern W, Peters A, Fruehwald-Schultes B, Deininger E, Born J, Fehm HL. 2001. Improving influence of insulin on cognitive functions in humans. Neuroendocrinology. 74:270-280. (Pubitemid 34701752)
30. Kubota N, Terauchi Y, Tobe K, Yano W, Suzuki R, Ueki K, Takamoto I, Satoh H, Maki T, Kubota T, et al. 2004. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest. 114:917-927. (Pubitemid 39578719)
31. Kullmann DM. 1994. Amplitude fluctuations of dual-component EPSCs in hippocampal pyramidal cells: implications for long-term potentiation. Neuron. 12:1111-1120. (Pubitemid 24178202)
32. Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, Kervinen K, Kesaniemi YA, Riekkinen PJ, Laakso M. 1997. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ. 315:1045-1049. (Pubitemid 27458392)
33. Lin JW, Ju W, Foster K, Lee SH, Ahmadian G, Wyszynski M, Wang YT, Sheng M. 2000. Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization. Nat Neurosci. 3:1282-1290.
34. Liu L, Brown JC, 3rd, Webster WW, Morrisett RA, Monaghan DT. 1995. Insulin potentiates N-methyl-D-aspartate receptor activity in Xenopus oocytes and rat hippocampus. Neurosci Lett. 192:5-8.
35. Liu SC, Wang Q, Lienhard GE, Keller SR. 1999. Insulin receptor substrate 3 is not essential for growth or glucose homeostasis. J Biol Chem. 274:18093-18099.
36. Luchsinger JA, Tang MX, Shea S, Mayeux R. 2004. Hyperinsulinemia and risk of Alzheimer disease. Neurology. 63:1187-1192. (Pubitemid 39350015)
37. Malenka RC, Nicoll RA. 1999. Long-term potentiation-a decade of progress? Science. 285:1870-1874.
38. Man HY, Wang Q, Lu WY, Ju W, Ahmadian G, Liu L, D'Souza S, Wong TP, Taghibiglou C, Lu J, et al. 2003. Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons. Neuron. 38:611-624. (Pubitemid 36645035)
39. Martin ED, Buno W. 2003. Caffeine-mediated presynaptic long-term potentiation in hippocampal CA1 pyramidal neurons. J Neurophysiol. 89:3029-3038. (Pubitemid 36682655)
40. Martin ED, Pozo MA. 2004. Valproate reduced excitatory postsynaptic currents in hippocampal CA1 pyramidal neurons. Neuropharmacology. 46:555-561. (Pubitemid 38224441)
41. Mastick CC, Saltiel AR. 1997. Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells. J Biol Chem. 272:20706-20714. (Pubitemid 27355635)
42. Messier C. 2005. Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol Aging. 26(Suppl 1):26-30.
43. Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C. 2010. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging. 31:224-243.
44. Myers MG, Jr., Backer JM, Sun XJ, Shoelson S, Hu P, Schlessinger J, Yoakim M, Schaffhausen B, White MF. 1992. IRS-1 activates phosphatidylinositol 3#-kinase by associating with src homology 2 domains of p85. Proc Natl Acad Sci USA. 89:10350-10354.
45. Nicoll RA, Malenka RC. 1999. Expression mechanisms underlying NMDA receptor-dependent long-term potentiation. Ann N Y Acad Sci. 868:515-525. (Pubitemid 29281159)
46. Nishijima T, Piriz J, Duflot S, Fernandez AM, Gaitan G, Gomez-Pinedo U, Verdugo JM, Leroy F, Soya H, Nuñ ez A, et al.2010. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS. Neuron. 67:834-846.
47. Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E, Bouschet T, et al. 2007. LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron. 53:703-717. (Pubitemid 46283369)
48. Poncer JC, Malinow R. 2001. Postsynaptic conversion of silent synapses during LTP affects synaptic gain and transmission dynamics. Nat Neurosci. 4:989-996. (Pubitemid 32924138)
49. Pons S, Rejas MT, Torres-Aleman I. 1991. Ontogeny of insulin-like growth factor I, its receptor, and its binding proteins in the rat hypothalamus. Brain Res Dev Brain Res. 62:169-175.
50. Raizada MK, Shemer J, Judkins JH, Clarke DW, Masters BA, LeRoith D. 1988. Insulin receptors in the brain: structural and physiological characterization. Neurochem Res. 13:297-303.
51. Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymate SR, Breitner JC, DeGroodt W, et al. 2008. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology. 70:440-448.
52. Rivera E, Ajani JA. 1998. Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma. Am J Clin Oncol. 21:36-38. (Pubitemid 28092969)
53. Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM. 2005. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis. 8:247-268.
54. Ronnemaa E, Zethelius B, Sundelof J, Sundstrom J, Degerman-Gunnarsson M, Berne C, Lannfelt L, Kilander L. 2008. Impaired insulin secretion increases the risk of Alzheimer disease. Neurology. 71:1065-1071.
55. Rostas JA, Brent VA, Voss K, Errington ML, Bliss TV, Gurd JW. 1996. Enhanced tyrosine phosphorylation of the 2B subunit of the Nmethyl-D-aspartate receptor in long-term potentiation. Proc Natl Acad Sci USA. 93:10452-10456.
56. Saal D, Dong Y, Bonci A, Malenka RC. 2003. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron. 37:577-582. (Pubitemid 36262980)
57. Schlessinger J, Mohammadi M, Margolis B, Ullrich A. 1992. Role of SH2-containing proteins in cellular signaling by receptor tyrosine kinases. Cold Spring Harb Symp Quant Biol. 57:67-74. (Pubitemid 23174377)
58. Schubert M, Brazil DP, Burks DJ, Kushner JA, Ye J, Flint CL, Farhang-Fallah J, Dikkes P, Warot XM, Rio C, et al. 2003. Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci. 23:7084-7092. (Pubitemid 36975873)
59. Selman C, Lingard S, Choudhury AI, Batterham RL, Claret M, Clements M, Ramadani F, Okkenhaug K, Schuster E, Blanc E, et al. 2008. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J. 22:807-818. (Pubitemid 351348133)
60. Shalin SC, Hernandez CM, Dougherty MK, Morrison DK, Sweatt JD. 2006. Kinase suppressor of Ras1 compartmentalizes hippocampal signal transduction and subserves synaptic plasticity and memory formation. Neuron. 50:765-779. (Pubitemid 43775734)
61. Sheng M. 2001. The postsynaptic NMDA-receptor-PSD-95 signaling complex in excitatory synapses of the brain. J Cell Sci. 114:1251. (Pubitemid 32409461)
62. Skeberdis VA, Lan J, Zheng X, Zukin RS, Bennett MV. 2001. Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis. Proc Natl Acad Sci USA. 98:3561-3566. (Pubitemid 32220884)
63. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP. 2008. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci. 11:309-317. (Pubitemid 351311802)
64. Sun XJ, Pons S, Asano T, Myers MG, Jr., Glasheen E, White MF. 1996. The Fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation. J Biol Chem. 271:10583-10587. (Pubitemid 26149894)
65. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF. 1991. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 352:73-77. (Pubitemid 21896701)
66. Unger J, McNeill TH, Moxley RT, 3rd, White M, Moss A, Livingston JN. 1989. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience. 31:143-157. (Pubitemid 19209704)
67. Van der Heide LP, Kamal A, Artola A, Gispen WH, Ramakers GM. 2005. Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J Neurochem. 94:1158-1166. (Pubitemid 41170602)
68. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, Kervinen K, Kesaniemi YA, Laakso M, Kuusisto J. 2006. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology. 67:843-847. (Pubitemid 44394200)
69. Vetiska SM, Ahmadian G, Ju W, Liu L, Wymann MP, Wang YT. 2007. GABAA receptor-associated phosphoinositide 3-kinase is required for insulin-induced recruitment of postsynaptic GABAA receptors. Neuropharmacology. 52:146-155. (Pubitemid 46039779)
70. Villasana LE, Klann E, Tejada-Simon MV. 2006. Rapid isolation of synaptoneurosomes and postsynaptic densities from adult mouse hippocampus. J Neurosci Methods. 158:30-36. (Pubitemid 44528760)
71. Wan Q, Xiong ZG, Man HY, Ackerley CA, Braunton J, Lu WY, Becker LE, MacDonald JF, Wang YT. 1997. Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature. 388:686-690. (Pubitemid 27366441)
72. Wang Q, Liu L, Pei L, Ju W, Ahmadian G, Lu J, Wang Y, Liu F, Wang YT. 2003. Control of synaptic strength, a novel function of Akt. Neuron. 38:915-928. (Pubitemid 36782383)
73. White MF. 1997. The insulin signalling system and the IRS proteins. Diabetologia. 40(Suppl 2):S2-S17. (Pubitemid 27306917)
74. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Jr., Yaffe K. 2005. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 330:1360.
75. Winder DG, Martin KC, Muzzio IA, Rohrer D, Chruscinski A, Kobilka B, Kandel ER. 1999. ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by beta-adrenergic receptors. Neuron. 24:715-726.
76. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF. 1999. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet. 23:32-40. (Pubitemid 29418784)
77. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:900-904. (Pubitemid 28157668)
78. Xu F, Plummer MR, Len GW, Nakazawa T, Yamamoto T, Black IB, Wu K. 2006. Brain-derived neurotrophic factor rapidly increases NMDA receptor channel activity through Fyn-mediated phosphorylation. Brain Res. 1121:22-34. (Pubitemid 44708893)
79. Yamato T, Misumi Y, Yamasaki S, Kino M, Aomine M. 2004. Diabetes mellitus decreases hippocampal release of neurotransmitters: an in vivo microdialysis study of awake, freely moving rats. Diabetes Nutr Metab. 17:128-136. (Pubitemid 39117272)
80. Ye P, Li L, Lund PK, D'Ercole AJ. 2002. Deficient expression of insulin receptor substrate-1 (IRS-1) fails to block insulin-like growth factor-I (IGF-I) stimulation of brain growth and myelination. Brain Res Dev Brain Res. 136:111-121. (Pubitemid 34718117)
81. Yu XM, Askalan R, Keil GJ, Salter MW. 1997. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science. 275:674-678. (Pubitemid 27061336)
82. Zhao W, Chen H, Xu H, Moore E, Meiri N, Quon MJ, Alkon DL. 1999. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem. 274:34893-34902. (Pubitemid 129509536)
83. Zucker RS. 1989. Short-term synaptic plasticity. Annu Rev Neurosci. 12:13-31. (Pubitemid 19085445)